Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $139.52 USD
Change Today -1.74 / -1.23%
Volume 137.5K
BIO On Other Exchanges
New York
New York
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christine A. Tsingos

Chief Financial Officer and Executive Vice President,Bio-Rad Laboratories, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Ms. Christine A. Tsingos has been Chief Financial Officer and Executive Vice President at Bio-Rad Laboratories, Inc. since December 2002 and 2012 respectively. Ms. Tsingos served as Vice President at Bio-Rad Laboratories, Inc. since 2003. She served as Chief Operating Officer and Chief Financial Officer at Attest Systems, Inc., from August 2002 to November 2002. Prior to that, She was a consultant to Attest Systems, Inc. from October 2000 to July 2002. She served as ...

Read Full Background

Corporate Headquarters*

1000 Alfred Nobel Drive
Hercules, California 94547

United States

Phone: 510-724-7000
Fax: 510-741-5817

Board Members Memberships*

Director, Chairman of Audit Committee and Member of Compensation Committee


George Washington University
American University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$423,330

Stock Options*

Restricted Stock Awards$239,080
All Other Compensation$15,043
Exercised Options7,000
Exercised Options Value$274,278
Exercisable Options9,140
Exercisable Options Value$244,082
Unexercisable Options8,310
Unexercisable Options Value$85,590
Total Value of Options$603,950
Total Number of Options24,450

Total Compensation*

Total Annual Cash Compensation$654,867
Total Short Term Compensation$423,330
Other Long Term Compensation$254,123
Total Calculated Compensation$962,190
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIO:US $139.52 USD -1.74


John L. Bishop Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Jonathan W. Ayers Chairman, Chief Executive Officer and President
IDEXX Laboratories, Inc.
Peer M. Schatz Chief Executive Officer and Managing Director
Qiagen NV
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
Namal Nawana Chief Executive Officer, President and Director
Alere Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-RAD LABORATORIES-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at